Akido Labs
-60%
est. 2Y upside i
Rebuilding healthcare with AI at the core
Rank
#3395
Sector
Healthcare Technology
Est. Liquidity
~4Y
Data Quality
Data: MediumThe expected equity upside over 2 years is -60%, driven by a stretched entry valuation (18.6x revenue) and high preference overhang ($95.6M).
Last updated: July 3, 2026
Exit at 15x revenue (~$530M) via IPO or acquisition, yielding $434M to common stock. Net of 15% dilution, equity appreciates 12.6%.
Exit at 8x revenue (~$282M), common gets $187M after preference. Dilution reduces further to -60.1%.
Multiple compresses to 4x revenue (~$141M) or lower; common stock value nearly wiped out after preferences and dilution.
Preference Stack Risk
highFunding Intensity
2810%Total preferred funding of $95.6M represents 28% of the current valuation, creating a significant overhang that must be overcome for common stock to realize value.
Dilution Risk
moderateThough profitable, the company may still raise capital for growth, likely resulting in 10-15% dilution over 2 years.
Secondary Liquidity
noneNo secondary market transactions are reported; any liquidity event is uncertain.
Other — 57 roles
- Certified Phlebotomy Technician (CPT), Full-Time · California
- Accounts Payable Clerk · Pomona, CA
- Clinic Office Supervisor - Cardiac Testing · Pomona, CA
- +54 more →
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Akido Labs's data — designed to show you've done your homework.
- 1
“How will Akido Labs differentiate its clinical AI platform against the scale and resources of Google Health and Microsoft DAX?”
- 2
“What is the unit economics of your care provider network, and how do they improve with scale?”
- 3
“Given the high preference overhang and no secondary market, what is the expected timeline to liquidity, and have you considered alternative structures like early exercise or Tender Offers?”
Community
Valuation Sentiment
Our model estimates -60% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.